- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06884189
Application of Plant Protection Products (PPP) in Apple Orchards (aPPPle)
Pilot Study on the Exposure of Operators, Residents and Workers to Plant Protection Products Used in Apple Orchards and Possible Health Effects
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Prof. Dr. Cornelia Weikert
- Phone Number: +49 301841255000
- Email: cornelia.weikert@bfr.bund.de
Study Contact Backup
- Name: Dr. Anna Lechner
- Phone Number: +49 301841255015
- Email: anna.lechner@bfr.bund.de
Study Locations
-
-
-
Berlin, Germany, 10589
- Recruiting
- Federal Institute for Risk Assessment
-
Contact:
- Prof. Dr. Cornelia Weikert
- Phone Number: +49 301841255000
- Email: cornelia.weikert@bfr.bund.de
-
Contact:
- Prof. Dr. Cornelia Weikert
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Users, residents and workers:
people from "Altes Land", a large apple-growing region in northern Germany
Control: live at least 10 km and max. 150 km away from agricultural apple orchards
Description
Inclusion Criteria:
- belonging to one of the defined study groups
- over 18 years of age at the time of recruitment
- person can understand the language and content of the study requirements
- person is capable of consenting to participate in the study and has given written consent to participate in the aPPPle study
- person has health insurance
Exclusion Criteria for residents and control:
person has direct professional contact with the tested substances acetamiprid, dithianon or dodine
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Operators
People who apply plant protection products to apple crops.
|
|
Workers
People who do manual work in apple cultivation, like pruning or harvesting.
|
|
Residents
People whose place of residence is adjacent to the orchard under investigation.
|
|
Control
People whose place of residence is at least 10 km away from agricultural apple orchards and a maximum of 150 km away from the apple orchard under investigation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concentration of plant protection substances/metabolites in different matrices
Time Frame: Operators: during the observed work with PPP and for urine up to 48 hours after; resident: during the observed application and for urine up to 48 hours after; workers: during work in the orchards and for urine up to 48 hours a; control: at one time point
|
The concentrations of the investigated substances/their metabolites will be analysed in urine, patches (to assess dermal exposure of the body), hand wipes (to assess dermal exposure of the hands), filters of an personal air sampler (to assess inhalation exposure), hair samples and gras samples
|
Operators: during the observed work with PPP and for urine up to 48 hours after; resident: during the observed application and for urine up to 48 hours after; workers: during work in the orchards and for urine up to 48 hours a; control: at one time point
|
|
Effect biomarkers in blood and metabolome in plasma
Time Frame: enrollment until 7 days after application/work in the apple orchards; for people from the control group at one time point
|
Defined effect biomarkers in blood as well as the metabolome in plasma will be analysed before and after application of plant protection products to observe possible early physiological changes. The following effect biomarkers in the blood will be measured: c-reactive protein, fasting glucose, HbA1c, cortisol, oxidized LDL, complete blood count, thyrotropin (TSH), free T3 (fT3), free T4 (fT4), gamma GT, GOT (ASAT), GPT (ALAT), bilirubin, cystatin C, urea |
enrollment until 7 days after application/work in the apple orchards; for people from the control group at one time point
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dermal Exposure
-
AllerganCompletedDermal NoduleUnited States
-
Church & Dwight Company, Inc.CompletedDermal IrritationUnited States
-
Asan Medical CenterCompletedDermal FillersKorea, Republic of
-
Steve Yoelin M.D. Medical Associates, Inc.Completed
-
University of ViennaMedical University of ViennaCompletedSkin Physiology | Dermal Administration | EmulsionsAustria
-
Joanneum Research Forschungsgesellschaft mbHCompletedHealthy | Dermal Pharmacokinetic MeasurementsAustria
-
Joanneum Research Forschungsgesellschaft mbHCompletedDermal Pharmacokinetic Measurements | Dermatology/Skin - OtherAustria
-
DEXLEVONot yet recruitingNasolabial Folds, Wrinkles | Dermal FillersRomania
-
International Centre for Diarrhoeal Disease Research...Completed
-
Cynosure, Inc.CompletedDermal and Epidermal Pigmented LesionsUnited States